AI-generated summary
The authors studied photobiomodulation, a form of light therapy, in 40 children and adolescents undergoing an allogeneic stem cell transplant for leukemia. Treatment was delivered daily at six sites, and the authors report that it was feasible and that treated patients had fewer hospitalization days and less severe mucositis than a matched control group.
- Participants
- 40
- Who or what was studied
- Children and adolescents with acute lymphoblastic leukemia or acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant
- Limits stated in the abstract
- The abstract reports a matched control comparison but does not describe the control group's size or design, and the authors' conclusion of effectiveness rests on this comparison.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, GRADE, Control group, Effect size, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.